Published in J Pain Symptom Manage on May 01, 1998
Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head Neck Oncol (2009) 1.22
The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage (2010) 1.12
A randomized trial of a representational intervention for cancer pain: does targeting the dyad make a difference? Health Psychol (2009) 1.05
Coping strategies, quality of life and pain in women with breast cancer. Iran J Nurs Midwifery Res (2013) 0.98
Effects of coaching patients with lung cancer to report cancer pain. West J Nurs Res (2010) 0.97
Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer (2011) 0.94
Comparative cognitive and subjective side effects of immediate-release oxycodone in healthy middle-aged and older adults. J Pain (2009) 0.92
White cancer patients' perception of gender and ethnic differences in pain experience. Cancer Nurs (2006) 0.90
Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain (2012) 0.90
Predictors of cancer-related pain improvement over time. Psychosom Med (2012) 0.87
Successful Pain Management for the Recovering Addicted Patient. Prim Care Companion J Clin Psychiatry (2002) 0.83
A randomized trial of weekly symptom telemonitoring in advanced lung cancer. J Pain Symptom Manage (2013) 0.82
Effects of brief pain education on hospitalized cancer patients with moderate to severe pain. Support Care Cancer (2004) 0.81
Cancer pain management at home (I): do older patients experience less effective management than younger patients? Support Care Cancer (2008) 0.81
"We all talk about it as though we're thinking about the same thing." Healthcare professionals' goals in the management of pain due to advanced cancer: a qualitative study. Support Care Cancer (2014) 0.77
"Why haven't you taken any pain killers?" A patient focused study of the walking wounded in an urban emergency department. Emerg Med J (2003) 0.77
Rationale, design, and implementation protocol of the Dutch clinical practice guideline pain in patients with cancer: a cluster randomised controlled trial with Short Message Service (SMS) and Interactive Voice Response (IVR). Implement Sci (2011) 0.76
Effects of chronic fentanyl administration on physical performance of aged rats. Exp Gerontol (2010) 0.76
The Pain Experience of Hispanic Americans: A Critical Literature Review and Conceptual Model. J Pain (2016) 0.75
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol (2013) 9.68
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol (1999) 4.12
Recognising clinical instability in hospital patients before cardiac arrest or unplanned admission to intensive care. A pilot study in a tertiary-care hospital. Med J Aust (1999) 3.76
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol (2001) 3.23
Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol (1997) 2.96
Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial. Ann Intern Med (1998) 2.58
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Primary care for survivors of breast cancer. N Engl J Med (2000) 2.39
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med (1997) 2.27
Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol (1999) 2.19
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol (1999) 2.03
Coagulation products and their uses. Am J Health Syst Pharm (2000) 2.02
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol (2001) 1.89
Weight gain in women diagnosed with breast cancer. J Am Diet Assoc (1997) 1.87
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr (2001) 1.84
Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos (2000) 1.80
Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol (1998) 1.66
Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg (1997) 1.53
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med (1997) 1.50
Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol (1996) 1.44
Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol (2000) 1.41
Paediatric hanging associated out of hospital cardiac arrest in Melbourne, Australia: characteristics and outcomes. Emerg Med J (2011) 1.41
Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr (1997) 1.37
Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer (1998) 1.34
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat (2011) 1.29
Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. Ann Oncol (2005) 1.25
Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol (2013) 1.24
NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park) (2000) 1.22
Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol (1993) 1.21
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat (2009) 1.19
Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med (1987) 1.18
Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas. J Neurooncol (1999) 1.16
Menopausal-type symptoms in young breast cancer survivors. Ann Oncol (2006) 1.15
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects. Clin Pharmacol Ther (2007) 1.13
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. Int J Radiat Oncol Biol Phys (1990) 1.06
Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract (2000) 1.05
Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med (2001) 1.05
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. J Natl Cancer Inst (1992) 1.04
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol (1999) 1.03
The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Res Treat (2008) 1.03
Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. Drug Metab Dispos (2001) 1.02
Cardiac arrest outcomes before and after the 2005 resuscitation guidelines implementation: evidence of improvement? Resuscitation (2011) 1.01
Out-of-hospital cardiac arrests in young adults in Melbourne, Australia. Resuscitation (2011) 1.01
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181. Cancer (2000) 1.01
Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol (2008) 0.99
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. Bone Marrow Transplant (2011) 0.98
Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol (2013) 0.96
Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? Ann Oncol (2012) 0.94
Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil. J Clin Pharmacol (2013) 0.93
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer. Ann Oncol (2011) 0.92
Granulocyte colony-stimulating factor use in cancer patients. Ann Pharmacother (2001) 0.91
Epidemiology of paediatric out-of-hospital cardiac arrest in Melbourne, Australia. Resuscitation (2010) 0.89
Skin reactions to radiotherapy--a spectrum resembling erythema multiforme: case report and review of the literature. Cutis (1992) 0.88
The effect of acute changes in coronary blood flow on left ventricular end-diastolic wall thickness. An echocardiographic study. Circulation (1977) 0.88
Phase I study of Doxil and vinorelbine in metastatic breast cancer. Ann Oncol (1999) 0.87
CMF revisited in the 21st century. Ann Oncol (2011) 0.85
Role of angiotensin II and vasopressin in cisplatin-induced emesis. Life Sci (1990) 0.85
Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis. J Clin Oncol (1999) 0.84
The influence of acute alterations in coronary blood flow on left ventricular diastolic compliance and wall thickness. Eur J Cardiol (1978) 0.84
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B. Thromb Haemost (1997) 0.84
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial. Cancer Res (1992) 0.84
New cytotoxic agents and schedules for advanced breast cancer. Semin Oncol (2001) 0.84
Oophoropexy and the management of Hodgkin's disease. A reevaluation of the risks and benefits. Arch Surg (1986) 0.84
Paediatric traumatic out-of-hospital cardiac arrests in Melbourne, Australia. Resuscitation (2011) 0.84
Thrombotic microangiopathy associated with chemotherapy: case report and review of the literature. DICP (1989) 0.83
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol (2012) 0.83
Out-of-hospital cardiac arrests in the older age groups in Melbourne, Australia. Resuscitation (2011) 0.83
Phase II evaluation of thalidomide in patients with metastatic breast cancer. J Clin Oncol (2000) 0.83
Primary tumors of the spine. Semin Musculoskelet Radiol (2000) 0.83
Liposomal anthracyclines for breast cancer. Semin Oncol (2001) 0.82
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group. J Clin Oncol (1999) 0.82
Does neoadjuvant bevacizumab increase surgical complications in breast surgery? Ann Surg Oncol (2010) 0.82
Out-of-hospital cardiac arrests in young adults in Melbourne, Australia-adding coronial data to a cardiac arrest registry. Resuscitation (2011) 0.82
Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial. Cancer Chemother Pharmacol (1997) 0.82
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation. Pharmacogenomics J (2007) 0.81
Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. Breast Dis (2001) 0.81
Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing. Cancer Chemother Pharmacol (2001) 0.81
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer. Ann Oncol (2013) 0.80
Patient Motivation, Satisfaction, and Coping in Genetic Counseling and Testing for BRCA1 and BRCA2. J Genet Couns (2000) 0.80
High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg (2001) 0.80
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors. J Clin Oncol (1994) 0.80
Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis. Med Decis Making (1999) 0.80
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer. Breast Cancer Res Treat (2013) 0.79
Heparin-bonded circuits decrease myocardial ischemic damage: an experimental study. Ann Thorac Surg (1997) 0.79
Adjuvant therapy of rectal cancer. Oncology (Williston Park) (1992) 0.78
Testing for hereditary breast and ovarian cancer in the southeastern United States. Ann Surg (2000) 0.78
Assessment of pain and patterns of analgesic use in hospice patients. Am J Hosp Palliat Care (1994) 0.78
The evaluation of cocaine-induced chest pain with acute myocardial perfusion imaging. Acad Emerg Med (1999) 0.78
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study. Blood Coagul Fibrinolysis (1993) 0.78
Overestimation of hereditary breast cancer risk. Ann Surg (1998) 0.78
Oral 5-FU analogues in the treatment of breast cancer. Oncology (Williston Park) (1998) 0.78
Soluble complement receptor type I limits damage during revascularization of ischemic myocardium. Ann Thorac Surg (1998) 0.77
Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization--preliminary findings. J Magn Reson Imaging (1998) 0.77
Factors contributing to patient satisfaction with breast reconstruction using silicone gel implants. Plast Reconstr Surg (1996) 0.77
Acute, reversible left ventricular dysfunction in status asthmaticus. Chest (1995) 0.76
Extreme warfarin intoxication secondary to possible covert drug ingestion. Drug Intell Clin Pharm (1988) 0.76
Pharmacy-perceived barriers to cancer pain control: results of the North Carolina Cancer Pain Initiative Pharmacist Survey. Ann Pharmacother (1994) 0.76
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer. Breast Cancer Res Treat (2013) 0.76
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study. Ann Pharmacother (2001) 0.75